BioWorld MedTech

May 20, 2016

Breakthrough techniques tap software to reveal causes of cardiac disease

PARIS – "If we can measure it, we can manage it" would have made a better title than "Imaging and Functional Assessment" for a session at EuroPCR 2016 presenting new techniques for cardiovascular diagnostics. Read More

Studies supportive of St. Jude's devices to treat HF, prevent stroke

Myriad opens patient portal as ACLU moves on gene data complaint

Efficacy comes to phase I cancer trials

With accelerated schedule, CFDA shoots for clarity

Other news to note

Daily M&A

Appointments and advancements

Product briefs

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for April 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 15, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Antibodies binding to spike proteins on the surface of SARS-CoV-2 virus

Australian researchers discover new compound to treat long COVID

BioWorld

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....

Blood glucose chart and monitor, stethoscope, injector pen

Hightide’s HTD-1801 meets phase III endpoints in type 2 diabetes

BioWorld

Hightide Therapeutics Inc.’s berberine ursodeoxycholate (HTD-1801) met primary and secondary endpoints in the Symphony 1 and Symphony 2 phase III trials in type 2...